Sensitivity of photoscreening to detect high-magnitude amblyogenic factors.

PURPOSE: To determine the sensitivity of a unique pupil-size based set of referral criteria of the MTI PhotoScreener(Medical Technology and Innovations, Inc, Cedar Falls, Iowa) to detect high magnitude refractive error. METHODS: The photoscreening photographs of 949 preschool children previously analyzed were reevaluated with the new referral criteria. The original photographs had been obtained from pediatricians' offices and public health and Women, Infants, and Children's (WIC) clinics. The results of this analysis were compared with the gold standard clinical examination and cycloplegic refraction. Sensitivities were calculated for amblyogenic factors based on the magnitude of the refractive error. RESULTS: For 26 patients with anisometropia, the sensitivity to detect anisometropia increased from 46% for +1.25 or greater spherical interocular difference to 100% for +2.50 spherical intraocular difference. For 36 patients with hypermetropia in at least 1 meridian ranging from +3.75 to +7.50 D, sensitivity increased from 53% to detect +3.75 D or greater to 70% for +5.00 D or greater. The sensitivity to detect hypermetropia of +5.75 D or greater was 100%. These criteria detected 82% of patients with astigmatism greater than or equal to +3.00 D, and 100% of patients with astigmatism greater than +3.50 D. CONCLUSION: It is crucial that screening programs avoid over-referrals caused by high false-positive screening rates. The sensitivity of our new criteria increases with higher magnitude refractive error; patients with moderate and severe amblyogenic factors are almost never missed. While the sensitivity to detect lower magnitude refractive error is poor, the amblyogenic impact of such errors remains to be determined.

The minimum occlusion trial for the treatment of amblyopia.

OBJECTIVE: To determine whether the traditional regimen of three intervals of full-time occlusion (FTO) for amblyopia without any measurable improvement in visual acuity constitutes an adequate trial. DESIGN: Retrospective, noncomparative, interventional case series. PARTICIPANTS: Sixty-four children younger than 10 years of age with unilateral amblyopia. METHODS: The medical records of patients treated for amblyopia in a university outpatient clinic were reviewed. Patients who underwent one FTO interval without an improvement in visual acuity followed by at least one additional FTO interval were included in the study. MAIN OUTCOME MEASURES: Improvement in visual acuity. RESULTS: Sixty-four patients underwent 81 occlusion trials consisting of one FTO interval without improvement followed by one or more FTO intervals. Visual acuity improved after the second FTO interval in 25 (31%) of the trials. Of the 44 occlusion trials consisting of two FTO intervals without improvement, visual acuity improved after the third FTO interval in 12 (27%) of the trials. Of the 11 occlusion trials consisting of three FTO intervals without improvement followed by one or more additional FTO intervals, acuity did not improve with any of the trials. CONCLUSIONS: A minimum of three intervals of FTO is necessary to determine whether an amblyopia patient will be unresponsive to occlusion therapy. After three FTO intervals without improvement, additional FTO is unlikely to result in an improvement in visual acuity.